Distinct risks of exacerbation and lung function decline between never-smokers and ever-smokers with COPD

被引:0
|
作者
Park, Heemoon [1 ]
Jo, Soo Min [2 ]
Jin, Kwang Nam [3 ]
Lee, Hyo Jin [1 ]
Lee, Hyun Woo [1 ]
Park, Tae Yun [1 ]
Heo, Eun Young [1 ]
Kim, Deog Kyeom [1 ]
Lee, Jung-Kyu [1 ]
机构
[1] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med,Seoul Metropolitan Govt, 20 Boramaero,5 Gil, Seoul 07061, South Korea
[2] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Seoul Metropolitan Govt, Goyang, South Korea
[3] Seoul Natl Univ, Boramae Med Ctr, Dept Radiol, Seoul Metropolitan Govt, Seoul, South Korea
来源
BMC PULMONARY MEDICINE | 2025年 / 25卷 / 01期
关键词
COPD; Never-smoker; Exacerbation; Lung function; OBSTRUCTIVE PULMONARY-DISEASE; POPULATION;
D O I
10.1186/s12890-025-03604-1
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundChronic obstructive pulmonary disease (COPD) can occur in patients without a history of smoking, which is a strong risk factor for COPD. However, few studies have focused on the prognosis of never-smokers with COPD. We investigated the difference of the longitudinal clinical outcomes between never-smokers and ever-smokers with COPD.MethodsWe retrospectively analyzed patients with COPD who underwent chest computed tomography and longitudinal lung function tests from January 2013 to December 2020. We classified patients according to smoking status and examined their histories of acute exacerbation and long-term changes in lung function.ResultsAmong 583 patients with COPD, 75 (12.9%) had no smoking history. These never-smokers with COPD were predominantly women; they had a lower forced vital capacity and a higher prevalence of asthma, history of tuberculosis, tuberculosis-destroyed lung, and bronchiectasis, but a lower prevalence of emphysema, relative to ever-smokers with COPD. Never-smokers with COPD had significantly lower risks of subsequent moderate to severe exacerbation (beta +/- standard error, - 0.4 +/- 0.12; P = 0.001), any exacerbation (adjusted odds ratio, 0.46; 95% confidence interval, 0.26 - 0.8; P = 0.006), and frequent exacerbation (adjusted odds ratio, 0.28; 95% confidence interval, 0.09 - 0.89; P = 0.03) than ever-smokers with COPD. Never-smokers with COPD also showed significantly slower annual decline of forced expiratory volume in 1 s than ever-smokers with COPD (- 15.7 +/- 4.7 vs. -30.4 +/- 2.9 mL, respectively; P = 0.03).ConclusionsNever-smokers with COPD had significantly fewer acute exacerbations and slower decline of lung function than ever-smokers with COPD during longitudinal follow-up.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Lung Cancer in 'Never-Smokers': A Unique Entity
    Subramanian, Janakiraman
    Govindan, Ramaswamy
    ONCOLOGY-NEW YORK, 2010, 24 (01): : 29 - 35
  • [42] Non-small cell lung cancer in never- and ever-smokers: Is it the same disease?
    Tang, Andrew
    Ahmad, Usman
    Toth, Andrew J.
    Bourdakos, Natalie
    Raja, Siva
    Raymond, Daniel P.
    Blackstone, Eugene H.
    Murthy, Sudish C.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 161 (06): : 1903 - +
  • [43] Lung epithelium DNA methylation: Electronic cigarette users, smokers, and never-smokers
    Song, Min-Ae
    Smiraglia, Dominic J.
    Brasky, Theodore M.
    Weng, Daniel Y.
    McElroy, Joseph P.
    Reisinger, Sarah A.
    Ying, Kevin L.
    Nickerson, Quentin A.
    Wewers, Mark D.
    Shields, Peter G.
    Freudenheim, Jo L.
    CANCER RESEARCH, 2018, 78 (13)
  • [44] Mechanisms of disease: signal transduction in lung carcinogenesis - a comparison of smokers and never-smokers
    Mountzios, Giannis
    Fouret, Pierre
    Soria, Jean-Charles
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (10): : 610 - 618
  • [45] Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung
    Nordquist, LT
    Simon, GR
    Cantor, A
    Alberts, WM
    Bepler, G
    CHEST, 2004, 126 (02) : 347 - 351
  • [46] Mechanisms of Disease: signal transduction in lung carcinogenesis—a comparison of smokers and never-smokers
    Giannis Mountzios
    Pierre Fouret
    Jean-Charles Soria
    Nature Clinical Practice Oncology, 2008, 5 : 610 - 618
  • [47] Correlation Between Emphysema and Lung Function in Healthy Smokers and Smokers With COPD
    Thomsen, Laura H.
    Shaker, Saher B.
    Dirksen, Asger
    Pedersen, Jesper H.
    Tal-Singer, Ruth
    Bakke, Per
    Vestbo, Jorgen
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2015, 2 (03): : 204 - 213
  • [48] Lung Cancer Risk Prediction Models for Asian Ever-Smokers
    Yang, Jae Jeong
    Wen, Wanqing
    Zahed, Hana
    Zheng, Wei
    Lan, Qing
    Abe, Sarah K.
    Islam, Rashedul
    Saito, Eiko
    Gupta, Prakash C.
    Tamakoshi, Akiko
    Koh, Woon-Puay
    Gao, Yu -Tang
    Sakata, Ritsu
    Tsuji, Ichiro
    Malekzadeh, Reza
    Sugawara, Yumi
    Kim, Jeongseon
    Ito, Hidemi
    Nagata, Chisato
    You, San -Lin
    Park, Sue K.
    Yuan, Jian-Min
    Shin, Myung-Hee
    Kweon, Sun-Seog
    Yi, Sang-Wook
    Pednekar, Mangesh S.
    Kimura, Takashi
    Cai, Hui
    Lu, Yukai
    Etemadi, Arash
    Kanemura, Seiki
    Wada, Keiko
    Chen, Chien-Jen
    Shin, Aesun
    Wang, Renwei
    Ahn, Yoon-Ok
    Shin, Min -Ho
    Ohrr, Heechoul
    Sheikh, Mahdi
    Blechter, Batel
    Ahsan, Habibul
    Boffetta, Paolo
    Chia, Kee Seng
    Matsuo, Keitaro
    Qiao, You -Lin
    Rothman, Nathaniel
    Inoue, Manami
    Kang, Daehee
    Robbins, Hilary A.
    Shu, Xiao-Ou
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (03) : 451 - 464
  • [49] DIFFERENCES BETWEEN SMOKERS AND NEVER-SMOKERS IN SENSITIVITY TO NICOTINE - A PRELIMINARY-REPORT
    POMERLEAU, OF
    HARIHARAN, M
    POMERLEAU, CS
    CAMERON, OG
    GUTHRIE, SK
    ADDICTION, 1993, 88 (01) : 113 - 118
  • [50] Germline mutations in young never-smokers with lung adenocarcinoma
    Luo, Wenxin
    Li, Weimin
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56